Epidemiologia da anafilaxia
Epidemiology of anaphylaxis
Elaine Gagete Miranda da Silva; Fábio F. Morato Castro
Resumo
A anafilaxia é uma doença de hipersensibilidade cujas características principais são a gravidade, a forma aguda de apresentação e sua possível evolução para choque e/ou falência respiratória caso o paciente não seja socorrido a tempo. Sua prevalência não é totalmente conhecida, variando de acordo com as regiões pesquisadas ao redor do mundo e, por razões ainda pouco conhecidas, está aumentando tanto em frequência quanto em gravidade. Através de estudos epidemiológicos é possível investigar-se melhor a doença, seus desencadeantes, os fatores a ela relacionados e sua prevenção. A presente revisão mostra os principais trabalhos epidemiológicos realizados sobre o tema nas últimas décadas.
Palavras-chave
Abstract
Anaphylaxis is a hypersensitivity disease whose main features are the severity, the acute presentation and the possible progression to shock and / or respiratory failure unless the patient is immediately treated. Its prevalence is not fully known, varying according to the surveyed areas around the world, and for reasons not fully understood, its frequency and severity are increasing. Through epidemiological studies, it is possible to better investigate the disease, its triggers and associated co-factors, and its prevention. This review addresses the major epidemiological studies conducted on the topic in recent decades.
Keywords
References
1. Joint Task Force of Practice Parameters. The diagnosis and management of anaphylaxis. J Allergy Clin Immunol. 1998; 101:S465–S528.
2. Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the Definition and Management of Anaphylaxis: Summary report. J Allergy Clin Immunol. 2005;115:584-91.
3. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: Summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117:391-7.
4. Simons FE, Ardusso LR, Bilò MB, Dimov V, Ebisawa M, El-Gamal YM, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12:389-99.
5. Simons FE, Ardusso LR, Bilò MB, Cardona V, Ebisawa M, El-Gamal YM, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7:9.
6. Campbell RL, Hagan JB, Manivannan V, Decker WW, Kanthala AR, Bellolio MF, et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012;129:748-52.
7. Samant SA, Campbell RL, Li JT. Anaphylaxis: diagnostic criteria and epidemiology. Allergy Asthma Proc. 2013;34:115-9.
8. Huang F, Chawla K, Järvinen KM, Nowak-Węgrzyn A. Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes. J Allergy Clin Immunol. 2012;129:162-8.
9. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using populationbased data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol. 2006;126:98-104.
10. O uso dos coeficientes, índices e razões e os indicadores de morbidade [site na Internet]. Disponível em: http://www.ee.usp. br/graduacao/ens435/modulo4/modulo4j.html (Acessado em 15/01/2014).
11. Lieberman P. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8:316-20.
12. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353-61.
13. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: A novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol. 2002;110:647‑51.
14. Ben-Shoshan M, Clarke AE. Anaphylaxis: past, present and future. Allergy. 2011;66:1-14.
15. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125:S161‑81.
16. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol. 1999;104:452-6.
17. Decker WW, Campbell RL, Manivannan V, Luke A, Sauver St. JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122:1161-5.
18. Rangaraj S, Tuthill D, Burr M, Alfaham M. Childhood epidemiology of anaphylaxis and epinephrine prescriptions in Wales: 1994-1999. J Allergy Clin Immunol. 2002;109:S75
19. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990–2006. Ann Allergy Asthma Immunol. 2008;101:387-93.
20. Sheikh A, Cox JH, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101:139-43.
21. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol. 2007;120:878-84.
22. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. 2007;62:91-6.
23. Gibbison B, Sheikh A, McShane P, Haddow C, Soar J. Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia. 2012;67:833-9.
24. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990–2006. Ann Allergy Asthma Immunol. 2008;101:387-93.
25. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using populationbased data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol. 2010;126:98-104.
26. Taback SP, Simons FE. Anaphylaxis and vitamin D: a role for the sunshine hormone? J Allergy Clin Immunol. 2007;120:128-30.
27. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol. 2007;120:878-84.
28. Ross Anderson H, Gupta R, Strachan DP, Limb ES. Fifty years of asthma: UK trends from 1955–2004.Thorax. 2007:62:85-90.
29. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006:117:367-77.
30. Warner JO. Anaphylaxis: the latest allergy epidemic. Pediatr Allergy Immunol. 2007;18:1-2.
31. Liew WK, Williamson E, Tang MLK. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434-42.
32. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119:1018-9.
33. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60:443-51.
34. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy. 2004;34:285-90.
35. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434-42.
36. Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783-9.
37. Simons FER. Anaphylaxis: Recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124:625-36.
38. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;6:327-80.
39. Hoffer V, Scheuerman O, Marcus N, Levy Y, Segal N, Lagovsky I, et al. Anaphylaxis in Israel: experience with 92 hospitalized children. Pediatr Allergy Immunol. 2011;22:172-7.
40. Sole D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LR, et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics (Sao Paulo). 2011;66:943-7.
41. De Swert LF, Bullens D, Raes M, Dermaux AM. Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach. Eur J Pediatr. 2008;167:1251-61.
42. Orhan F, Canitez Y, Bakirtas A, Yilmaz O, Boz AB, Can D, et al. Anaphylaxis in Turkish children: a multi-centre, retrospective, case study. Clin Exp Allergy. 2011;41:1767-76.
43. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy. 2003;33:1033-40.
44. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med. 2005;28:381-8.
45. Moro Moro M, Tejedor Alonso MA, Esteban Hernández J, Múgica García MV, Rosado Ingelmo A, Vila Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol. 2011;21:142-9.
46. Cianferoni A, Novembre E, Pucci N, Lombardi E, Bernardini R, Vierucci A. Anaphylaxis: a 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol. 2004;92:464-8.
47. Guerra Bernd LA, Arruda LK, Barros Antunes HB. Oral anaphylaxis to mites. Allergy. 2001;56:83-4.
48. Geller M, Ludwig Hahnstadt R, Malheiros Rego R, Fernandez-Caldas E. Anafilaxia induzida por farinha de trigo contaminada por ácaros. Rev Bras Alerg Imunopatol. 2009;32:199-201.
49. Sánchez-Borges M, Iraola V, Fernández-Caldas E, Capriles-Hulett A, Caballero-Fonseca F. Dust mite ingestion-associated, exerciseinduced anaphylaxis. J Allergy Clin Immunol. 2007;120:714-6.
50. Audicana MT, Kennedy MW. Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity. Clin Microbiol Rev. 2008;21:360-79.
51. Ohgiya Y, Arakawa F, Akiyama H, Yoshioka Y, Hayashi Y, Sakai S, et al. Molecular cloning, expression, and characterization of a major 38-kd cochineal allergen. J Allergy Clin Immunol. 2009;123:1157‑62.
52. Sampson HA, Burks AW. Adverse reactions to foods. In: Adkinson NF, Busse W, Bochner B, Holgate S, Simons FE, Lemanske Jr R. Middleton's Allergy: Principles and Practice. Michigan: Elsevier; 2009. p. 1139-67.
53. Castro FFM, Palma MS. Alergia a Venenos de Insetos. 1ª ed. São Paulo: Manole Editora Ltda.; 2009.
54. Bonadonna P, Zanotti R, Müller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10:347-53.
55. Rubio M, Bousquet PJ, Demoly P, Chung CH, Mirakhur B, Chan E, et al. Update in drug allergy: novel drugs with novel reaction patterns. Curr Opin Allergy Clin Immunol. 2010;10:457-62.
56. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab- induced anaphylaxis and IgE specific for galactosealpha-1,3-galactose. N Engl J Med. 2008;358:1109-17.
57. Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003;98:1315-24.
58. Limb SL, Starke PR, Lee CE, Chowdhury BA. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol. 2007;120:1378-81.
59. Rezvani M, Bernstein DI. Anaphylactic reactions during immunotherapy. Immunol Allergy Clin North Am. 2007;27:295‑307.
60. Rodriguez-Perez N, Ambriz MM, Canonica GW, Penagos M. Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann Allergy Asthma Immunol. 2008;101:304-10.
61. Kelso JM, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, et al. Adverse reactions to vaccines. Ann Allergy Asthma Immunol. 2009;103:1-14.
62. Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy. 2009;64:234-41.
63. Yunginger JW. Natural rubber latex allergy. In: Adkinson NF, Busse W, Bochner B, Holgate S, Simons FE, Lemanske Jr R. Middleton's Allergy: Principles and Practice. Michigan: Elsevier; 2009. p.1019‑26.
64. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415-8.
65. Barg W, Medrala W, Wolanczyk MA. Exercise-Induced Anaphylaxis: An Update on Diagnosis and Treatment. Curr Allergy Asthma Rep. 2011;11:45-51.
66. Basagana M, Bartolome B, Pastor C, Torres F, Alonso R, Vivanco F, et al. Allergy to human seminal fluid: cross-reactivity with dog dander. J Allergy Clin Immunol. 2008;121:233-39.
67. Commins SP, Satinover SM, Hosen J, Mozena J, Borish L, Lewis BD, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-a1,3-galactose. J Allergy Clin Immunol. 2009;123:426-33.
68. Samant SA, Campbell RL, Li JT. Anaphylaxis: diagnostic criteria and epidemiology. Allergy Asthma Proc. 2013;34:115-9.
69. Iribarren C, Tolstykh IV, Miller MK, Eisner MD. Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol. 2010;104:371-7.
70. Fallon PG, Emson CL, Smith P, McKenzie ANJ. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J Immunol. 2001;166:2712-6.
71. Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstein L, Nicklas RA. The diagnosis and management of anaphylaxis: An updated practice parameter. J Allergy Clin Immunol. 2005;115:483-524.
72. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007;98:252-7.
73. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol. 2007;7:337-41.
74. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy. 2003;33:1033-40.
75. Ellis AK. Biphasic Anaphylaxis: A Review of the Incidence, Characteristics and Predictors. Open Allergy J. 2010;3:24-8.
76. Tang MLK, Osborne N, Allen K. Epidemiology of anaphylaxis. Cur Opin Allergy Clin Immunol. 2009;9:351–6.
77. de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy. 2008;63:1071-6.
78. Bernd LAG, Fleig F, Alves MB, Bertozzo R, Coelho M, Correia J, et al. Anafilaxia no Brasil – Levantamento da ASBAI. Rev Bras Alerg Imunopatol. 2010;33:190-8.
Submitted date:
06/15/2014
Accepted date:
09/27/2014
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email